Ju Yuefeng, Wang MaoJing, Ji Yang, Wang Zhihui, Wang Wenzhuo, Liu Feiyue, Zhao Qing
Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Front Cardiovasc Med. 2025 May 2;12:1512187. doi: 10.3389/fcvm.2025.1512187. eCollection 2025.
The complement system plays a crucial role in the pathogenesis and progression of cardiovascular diseases. C1q, a key initiator of the classical pathway, is closely associated with various chronic inflammatory conditions. This observational study aims to elucidate the potential risk relationship between serum complement C1q levels and atrial fibrillation (AF).
This retrospective cohort study included 812 AF patients treated at the Affiliated Hospital of Qingdao University from January 2020 to October 2022, comprising 694 patients in the paroxysmal AF group and 118 in the persistent AF group. Serum complement C1q levels were measured using an enzyme-linked immunosorbent assay (ELISA).
Serum C1q levels in the AF group were significantly lower than those in the control group ( < 0.001). Logistic regression analysis indicated that reduced plasma C1q levels were independently associated with the incidence of AF (95% CI = 0.974-0.981, = 0.001). Additionally, ROC curve analysis confirmed the close association between plasma C1q levels and AF, highlighting the predictive value of C1q for AF. Further investigation revealed that C1q serves as an independent risk factor for complex fractionated atrial electrograms (CFAE) in the superior left atrium of paroxysmal AF patients (95% CI = 0.984-0.998, = 0.031), suggesting its potential as a clinical indicator for guiding AF surgical interventions.
Serum C1q levels are significantly reduced in patients with AF. The presence of CFAE in the superior left atrium of paroxysmal AF patients may be potentially associated with C1q levels. Low complement levels are associated with atrial fibrillation compared to individuals without AF and may represent a potential underlying cause of impaired sinus rhythm maintenance following pulmonary vein isolation. Complement C1q may play a critical role in the pathogenesis of AF.
补体系统在心血管疾病的发病机制和进展中起关键作用。C1q是经典途径的关键启动因子,与多种慢性炎症状态密切相关。本观察性研究旨在阐明血清补体C1q水平与心房颤动(AF)之间的潜在风险关系。
这项回顾性队列研究纳入了2020年1月至2022年10月在青岛大学附属医院接受治疗的812例AF患者,其中阵发性AF组694例,持续性AF组118例。采用酶联免疫吸附测定(ELISA)法检测血清补体C1q水平。
AF组血清C1q水平显著低于对照组(<0.001)。Logistic回归分析表明,血浆C1q水平降低与AF的发生率独立相关(95%CI = 0.974 - 0.981, = 0.001)。此外,ROC曲线分析证实血浆C1q水平与AF密切相关,突出了C1q对AF的预测价值。进一步研究发现,C1q是阵发性AF患者左上心房复杂碎裂电位(CFAE)的独立危险因素(95%CI = 0.984 - 0.998, = 0.031),表明其作为指导AF手术干预的临床指标的潜力。
AF患者血清C1q水平显著降低。阵发性AF患者左上心房存在CFAE可能与C1q水平潜在相关。与无AF个体相比,补体水平低与心房颤动相关,可能是肺静脉隔离后窦性心律维持受损的潜在根本原因。补体C1q可能在AF的发病机制中起关键作用。